Novel Insights and Advances in Aquatic Vaccines

Dear Colleagues,

As one of the fastest growing sources for high-quality proteins, aquaculture significantly contributes to the world food security. Disease prevention and control is indispensable for a healthy and sustainable aquaculture industry. Vaccination has been one of the most effective methods to control the emerging and re-emerging infectious diseases in aquaculture. Moreover, aquatic vaccines have shown potential beneficial effects on human health by overcoming negative effects due to the abuse of pharmaceuticals and antibiotics, as well as their residues in food and the environment. From the perspective of sustainability and prosperity in aquaculture, vaccination has been considered a crucial part of comprehensive fish health management. In recent decades, scientific and technological advances have paved newer paths in both basic and applied research areas of aquatic vaccines. Efforts in new technologies, approaches and strategies have been devoted to developing and designing novel aquatic vaccines with a higher quality and efficiency. Reverse vaccinology and structural vaccinology were also employed to screen stronger antigens and develop immunomics-based and computer-aided vaccines. Genetic engineering recombinant and chemical methods were applied to design adjuvant vaccines, polyvalent and combination vaccines, nanoparticle-based vaccines/nanovaccines and targeted vaccines. Moreover, novel insights also have been proposed to reveal the immunoprotective mechanism of aquatic vaccines and enrich the knowledge of immune response mechanism including mucosal immunity and systemic immunity in aquatic species.

Dr. Erlong Wang
Dr. Tao Liu
Dr. Yibin Yang
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• aquatic vaccines
• polyvalent vaccines
• combination vaccines
• adjuvant vaccines
• vaccination routes
• immersion vaccines